AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Multiple Myeloma (MM)

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFYยฎ+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma NCT05645107Phase 362 sites๐Ÿ“ Bullhead City๐Ÿ“ Huntington Park๐Ÿ“ St. Petersburg Grifols Therapeutics LLC ยท Tests: Xembify, Placebo Universal CAR-T Cell Therapy for MM NCT07248176NA1 site๐Ÿ“ Shanghai Bioray Laboratories ยท Tests: Targeted BCMA Gene-Modified Allogeneic Chimeric Antigen Receptor T-Cell Injection Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma NCT07236502NA2 sites๐Ÿ“ Maywood๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: Immediate intervention, Waitlist A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study NCT06271252Phase 11 site๐Ÿ“ Atlanta OriCell Therapeutics Co., Ltd. ยท Tests: OriCAR-017 A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPROยฎ in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma NCT07477587Phase 184 sites๐Ÿ“ Springdale๐Ÿ“ Jacksonville๐Ÿ“ Margate Shanghai Henlius Biotech ยท Tests: HLX15-SC-Rd, US-DARZALEX FASPROยฎ-Rd Real-World Mapping Antithrombotic Regimens in MM Patients on Treatment NCT06028087n/a1 site๐Ÿ“ Roma Gruppo Italiano Malattie EMatologiche dell'Adulto Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD NCT05530096n/a1 site๐Ÿ“ Montreal Sir Mortimer B. Davis - Jewish General Hospital ยท Tests: Standard of care Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma NCT07333430Phase 11 site๐Ÿ“ Jerusalem Hadassah Medical Organization ยท Tests: Naive HBI0101 CAR-T PASCA-MM Study. Impact of the PASCA (PArcours de Santรฉ au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70. NCT05947136NA6 sites๐Ÿ“ ร‰pagny๐Ÿ“ Grenoble๐Ÿ“ Lyon Centre Leon Berard ยท Tests: Interpretation of the results from the detection visit, Explaining detection results and referrals to the patient, Earlโ€ฆ A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma NCT07637578Phase 26 sites๐Ÿ“ Denver๐Ÿ“ Denver๐Ÿ“ Columbia SCRI Development Innovations, LLC ยท Tests: Elranatamab, Tocilizumab Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research NCT07085559EARLY Phase 11 site๐Ÿ“ Hefei Anhui Provincial Hospital ยท Tests: Metabolically Armed BCMA CAR-T cells. Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma NCT05972135Phase 217 sites๐Ÿ“ Tucson๐Ÿ“ Denver๐Ÿ“ Denver SCRI Development Innovations, LLC ยท Tests: Teclistamab, Talquetamab, Tocilizumab, Oral Dexamethasone Exercise Phenotyping Prior to Chemotherapy in Newly Diagnosed Multiple Myeloma (MM-Exercise) NCT07851493n/a1 site๐Ÿ“ Munich Technical University of Munich A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM) NCT06953960Phase 1, Phase 251 sites๐Ÿ“ Los Angeles๐Ÿ“ New Haven๐Ÿ“ Boston AbbVie ยท Tests: Surzetoclax, Daratumumab, Dexamethasone, Pomalidomide, Etentamig A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma NCT07116616Phase 1, Phase 210 sites๐Ÿ“ Birmingham๐Ÿ“ San Francisco๐Ÿ“ Atlanta ModernaTX, Inc. ยท Tests: mRNA-2808 Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration NCT07003555Phase 11 site๐Ÿ“ Shanghai Beijing GoBroad Hospital ยท Tests: Dual-targeting BCMA-CD19 CAR-T cell infusion A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL). NCT07638683Phase 21 site๐Ÿ“ Shanghai Shanghai Zhongshan Hospital ยท Tests: Teclistamab MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) NCT06152575Phase 3270 sites๐Ÿ“ Mobile๐Ÿ“ Goodyear๐Ÿ“ Beverly Hills Pfizer ยท Tests: Elranatamab, Elotuzumab, Pomalidomide, Dexamethasone, Bortezomib CAR-T Immunomonitoring in Multiple Myeloma (CART I5M) NCT07342179NA1 site๐Ÿ“ Poitiers Poitiers University Hospital ยท Tests: Additional Bone Marrow cells and blood sampling A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM) NCT07393282Phase 327 sites๐Ÿ“ Phoenix๐Ÿ“ Atlanta๐Ÿ“ Boston Regeneron Pharmaceuticals ยท Tests: Linvoseltamab, Daratumumab Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies NCT07648264Phase 360 sites๐Ÿ“ Orange๐Ÿ“ Denver๐Ÿ“ Coral Springs CSL Behring ยท Tests: IgPro20 AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma NCT06106945Phase 1, Phase 246 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ Atlanta AstraZeneca ยท Tests: AZD0305, Elranatamab, Pomalidomide, Dexamethasone Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies NCT07270263NA1 site๐Ÿ“ Gdansk Medical University of Gdansk ยท Tests: Apixaban, Rivaroxaban, low molecular weight heparin (enoxaparin sodium) DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM NCT07377435Phase 11 site๐Ÿ“ Boston David Avigan ยท Tests: DC/MM Fusion Vaccine, GM-CSF Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM NCT06518551Phase 1, Phase 23 sites๐Ÿ“ Boston๐Ÿ“ Boston๐Ÿ“ Boston Omar Nadeem, MD ยท Tests: Elotuzumab, Iberdomide, Dexamethasone Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration NCT07003568Phase 11 site๐Ÿ“ Shanghai Beijing GoBroad Hospital ยท Tests: Dual-targeting BCMA-GPRC5D CAR-T cell infusion A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM) NCT07771803EARLY Phase 11 site๐Ÿ“ Camden Roger Strair ยท Tests: Soursop tea Human BCMA Targeted T Cells Injection๏ผˆBCMA CAR-T๏ผ‰for Subjects With R/R MM NCT05594797Phase 22 sites๐Ÿ“ Shanghai๐Ÿ“ Wenzhou Hrain Biotechnology Co., Ltd. ยท Tests: Human BCMA Targeted T Cells Injection CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment NCT07585760Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: CM336 Plus Isatuximab Randomised Controlled Trial of Artificial Intelligence-assisted Health Education NCT07305337NA1 site๐Ÿ“ Wuhan Zhongnan Hospital ยท Tests: Artificial Intelligence Health Education, Artificial health education
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy